BMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/9 tion of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003, 12:674-647. 32. Taylor RM, Thistlethwaite A, Caldecott KW: Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol 2002, 22:2556-2563. 33. Wilson DM III, Thompson LH: Life without DNA repair. Proc Natl Acad Sci 1997, 94:12754-12757. 34. Rutter JL, Smith A, Davila M, Sigurdson AJ, Doody MM, Tucker MA, Greene M, Struewing JP: Mutational analysis of BRCA1-interact- ing genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and ref- erence individuals. Hum Mutat 2003, 22:121-128. 35. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN: Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer 2003, 107:60-64. 36. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS: Insulin-like growth factor-I in relation to premenopausal ductal carci- noma in situ of the breast. Epidemiology 1998, 9:570-573. 37. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirer O: Polymorphisms of the transforming growth factor b1 gene in relation to myocar- dial infarction and blood pressure. Hypertension 1996, 28:881-887. 38. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS: Association between the T29-->C polymorphism in the transforming growth factor beta 1 gene and breast cancer among elderly white women: the study of osteoporotic fractures. JAMA 2001, 285:2859-2863. 39. Dunning AM, Ellis Pd, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalf JC: A transforming growth factor ß1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63:2610-2615. 40. Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA: A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 2000, 26:362-364. 41. Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Che- nevix-Trench G: The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 2002, 11:413-416. 42. Auranen A, Spurdle AB, Chen X, Lipscombe J, Purdie DM, Hopper JL, Green A, Healey CS, Redman K, Dunning AM, Pharoah PD, Easton DF, Ponder BA, Chenevix-Trench G, Novik KL: BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk. Int J Cancer 2003, 103:427-430. 43. Airewele G, Adatto P, Cunningham J, Mastromarino C, Spencer C, Sharp M, Sigurdson A, Bondy M: Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Can- cer Inst 1998, 90:543-544. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/4/9/prepub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 12 of 12 (page number not for citation purposes)